fbpx

Posted on August 20, 2018

Major breakthrough identifies new mechanism for the development of schizophrenia

Mouse hippocampus injected with adeno-associated virus (AAV) expressing green fluorescent protein. Credit: Dr Matthew Campbell, Trinity College Dublin.

Scientists from Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI) have discovered that abnormalities of blood vessels in the brain may play a major role in the development of schizophrenia, a debilitating condition that affects around 1% of people in Ireland.

The network of blood vessels in the  regulates the transport of energy and materials in and out of the brain—forming what is known as the blood-brain barrier (BBB). Scientists working in the Smurfit Institute of Genetics at Trinity College Dublin and the Department of Psychiatry, RCSI, have discovered that abnormalities in the integrity of the BBB may be a critical component in the development of  and other brain disorders.

The research, published today in the leading international journal Molecular Psychiatry, was supported by the Health Research Board (HRB), Science Foundation Ireland (SFI) and the US-based charity, Brightfocus Foundation.

People living with a chromosomal abnormality termed ’22q11 deletion syndrome’ (22q11DS) are 20 times more likely to develop schizophrenia. These people lack approximately 40-60 genes within a small region in one of the pairs of chromosome 22. A gene termed “Claudin-5” is located within this region, and it is changes in the levels of this component of the BBB that are associated with the presence of schizophrenia.

Major breakthrough identifies new mechanism for the development of schizophrenia
Human schizophrenia patient brain stained for blood-brain barrier (BBB) component claudin-5 (red). Credit: Dr Matthew Campbell, Trinity College Dublin.

Assistant Professor in Neurovascular Genetics at Trinity, Dr Matthew Campbell, said: “Our recent findings have, for the first time, suggested that schizophrenia is a brain disorder associated with abnormalities of . The concept of tailoring drugs to regulate and treat abnormal brain  is a novel treatment strategy and offers great potential to complement existing treatments of this debilitating disease.”

“While it is very well accepted that improving cardiovascular health can reduce the risk of stroke and heart attacks, we now believe that drugs aimed at improving cerebrovascular health may be an additional strategy to treating brain diseases in the future.”

Working with an international group of scientists from Cardiff University, Stanford University and Duke University in addition to screening post-mortem brain samples from the Stanley Medical Research Institute, the scientists are the first to identify a molecular genetic component of the  with the development of schizophrenia.

Professor Kieran Murphy, Head of Department of Psychiatry, RCSI and Consultant Psychiatrist at Beaumont Hospital, said: “We have shown for the first time that dysfunction of the  may be an important factor in the development of schizophrenia. These findings greatly add to our understanding of this debilitating and socially isolating condition.”

Applications for Fall 2022 are Now Closed!

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close